ABBOTT LABORATORIES - COM (ABT)

Historical Holders from Q1 2014 to Q1 2025

Symbol
ABT on NYSE
CUSIP
002824100
Type / Class
Equity / COM
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.34B
Holdings value
$152B
% of all portfolios
0.13%
Grand Portfolio weight change
+0.012%
Number of holders
2991
Number of buys
1202
Number of sells
-1248
Average Value change %
-0.02%
Average buys %
+0.008%
Average sells %
-0.031%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ABBOTT LABORATORIES - COM (ABT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 28.1M $3.73B +$175M $132.65 610
2024 Q4 1.34B $152B +$6.81B $113.11 2,991
2024 Q3 1.28B $146B -$4.17B $114.01 2,856
2024 Q2 1.32B $137B +$3.85B $103.91 2,818
2024 Q1 1.28B $145B -$2.87B $113.66 2,874
2023 Q4 1.3B $143B +$2.99B $110.07 2,808
2023 Q3 1.27B $123B +$509M $96.85 2,623
2023 Q2 1.28B $139B -$2.12B $109.02 2,674
2023 Q1 1.28B $130B +$626M $101.26 2,647
2022 Q4 1.29B $141B +$395M $109.79 2,704
2022 Q3 1.29B $125B +$273M $96.76 2,563
2022 Q2 1.27B $138B +$1.37B $108.65 2,641
2022 Q1 1.28B $152B -$1.51B $118.36 2,708
2021 Q4 1.28B $180B -$1.01B $140.74 2,767
2021 Q3 1.3B $153B -$417M $118.13 2,493
2021 Q2 1.3B $151B -$1.53B $115.93 2,467
2021 Q1 1.31B $157B +$1.34B $119.84 2,485
2020 Q4 1.27B $139B +$205M $109.49 2,441
2020 Q3 1.3B $142B -$20.6M $108.83 2,272
2020 Q2 1.3B $119B -$1.23B $91.43 2,217
2020 Q1 1.28B $101B +$339M $78.91 2,094
2019 Q4 1.3B $113B +$655M $86.86 2,163
2019 Q3 1.32B $110B +$66.7M $83.67 2,007
2019 Q2 1.31B $110B +$3.31B $84.10 1,987
2019 Q1 1.29B $103B -$654M $79.94 1,978
2018 Q4 1.32B $95.4B +$1.9B $72.33 1,950
2018 Q3 1.27B $93.4B +$2.94B $73.36 1,843
2018 Q2 1.25B $76.5B +$96.5M $60.99 1,789
2018 Q1 1.27B $76.2B +$363M $59.92 1,784
2017 Q4 1.27B $72.3B -$444M $57.07 1,733
2017 Q3 1.27B $67.9B +$611M $53.36 1,582
2017 Q2 1.26B $61.1B +$727M $48.61 1,559
2017 Q1 1.25B $55.5B +$10.5B $44.41 1,579
2016 Q4 1.1B $42.4B +$383M $38.41 1,507
2016 Q3 1.09B $46.1B +$1.05B $42.29 1,476
2016 Q2 1.06B $41.8B +$1.69B $39.31 1,461
2016 Q1 1.02B $42.7B -$167M $41.83 1,453
2015 Q4 1.03B $46.1B -$502M $44.91 1,494
2015 Q3 1.03B $41.6B +$281M $40.22 1,448
2015 Q2 1.01B $49.6B +$345M $49.08 1,473
2015 Q1 1.03B $47.6B -$628M $46.33 1,458
2014 Q4 1.04B $46.9B +$358M $45.02 1,463
2014 Q3 1.03B $42.7B +$357M $41.59 1,382
2014 Q2 1.02B $41.7B +$108M $40.90 1,372
2014 Q1 1.02B $39.2B -$1.31B $38.51 1,363